Global Stye Drug Market is Booming Market Growing by 2026 with Top Key Players
Posted: Nov 16, 2019
Global stye drug market By Type (External Hordeolum and Internal Hordeolum), Therapy Type (Antibiotic Therapy and Eye Warming Therapy), Treatment Type (Medication and Surgery), Drug Class Type (Antibiotics and Ophthalmic Steroids), Route of Administration (Oral and Topical), End-Users (Hospitals, Homecare, Specialty Clinics, Others)Market Analysis: Global Stye Drug Market
Global stye drug market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. Growing population of stye population worldwide and emergence of drugs used in the treatment of risk associated with stye disease are the key factors to drive the market growth.
A sample of this report is available upon request @
Stye is also known as hordeolum is an ocular disease in which small lumps grows at the edge of eyelids or at the base of the eyelashes. It is caused by bacterial infections. The patients with stye may experience inflammation of eyes, swelling and tearing.
According to the article published in Jobson Medical Information LLC, it is estimated that total population of allergic conjunctivitis is up to 30% of general population worldwide. Exposure to certain toxin or change in environment may enhance the prevalence of stye infections which acts as a key factor for the market growth.
- Ongoing clinical trial studies being carried out by many pharmaceuticals industries
- Exposure to certain toxin or change in environment may increase the stye infections
- Prevalence of indoor as well as outdoor allergens
- Increase in prevalence rate of stye disease worldwide
stye drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Stye Drug for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Segmentation: Global Stye Drug Market
- External hordeolum
- Internal hordeolum
By Therapy Type
- Antibiotics Therapy
- Eyes Warming Therapy
By Drug Class
- Ophthalmic Steroids
By Route of Administration
By End Users
- Specialty Clinics
Key Developments in the Market:
In August 2018, Senju USA, Inc. conducting phase III (SUNRISE) clinical trial for their lead candidate SUN 131 TDS to evaluate the safety and efficacy in patients with chalazion. If approved it will represent a new and significant treatment options for chalazion.
In September 2015, Sun Pharmaceutical Industries Ltd acquired InSite Vision Inc for up to USD 48.00mm. The acquisitions of InSite Vision Inc, strengthens the branded ophthalmic portfolio of Sun Pharmaceutical Industries Ltd in the United States.
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Report RelatedEurope Drug Safety Solutions and Pharmacovigilance Market
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.